The online home of Neurology Reviews

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Marijuana for migraine? Some tentative evidence

Publish date:: June 24, 2020

Key clinical point: Patients with comorbid anxiety and insomnia seemed to fare particularly well.

Major finding: Percentage who used abortive drugs at least 10 days a month dropped from 46.4% to 25.0%.

Study details: Prospective analysis (n = 48).

Disclosures: The study received no funding.

Citation:

Marmura MJ et al. AHS 2020, Abstract 842679.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,